NRXS Relative Valuation
NRXS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NRXS is overvalued; if below, it's undervalued.
Historical Valuation
Neuraxis Inc (NRXS) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -17.39. The fair price of Neuraxis Inc (NRXS) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：2.80
Fair
-3.74
PE
1Y
3Y
5Y
Trailing
Forward
-3.14
EV/EBITDA
Neuraxis Inc. (NRXS) has a current EV/EBITDA of -3.14. The 5-year average EV/EBITDA is -0.59. The thresholds are as follows: Strongly Undervalued below -2.98, Undervalued between -2.98 and -1.78, Fairly Valued between 0.60 and -1.78, Overvalued between 0.60 and 1.79, and Strongly Overvalued above 1.79. The current Forward EV/EBITDA of -3.14 falls within the Strongly Undervalued range.
-3.09
EV/EBIT
Neuraxis Inc. (NRXS) has a current EV/EBIT of -3.09. The 5-year average EV/EBIT is -19.36. The thresholds are as follows: Strongly Undervalued below -49.47, Undervalued between -49.47 and -34.42, Fairly Valued between -4.31 and -34.42, Overvalued between -4.31 and 10.74, and Strongly Overvalued above 10.74. The current Forward EV/EBIT of -3.09 falls within the Overvalued range.
5.75
PS
Neuraxis Inc. (NRXS) has a current PS of 5.75. The 5-year average PS is 2.42. The thresholds are as follows: Strongly Undervalued below -0.55, Undervalued between -0.55 and 0.93, Fairly Valued between 3.91 and 0.93, Overvalued between 3.91 and 5.40, and Strongly Overvalued above 5.40. The current Forward PS of 5.75 falls within the Strongly Overvalued range.
-3.95
P/OCF
Neuraxis Inc. (NRXS) has a current P/OCF of -3.95. The 5-year average P/OCF is -0.75. The thresholds are as follows: Strongly Undervalued below -3.76, Undervalued between -3.76 and -2.25, Fairly Valued between 0.75 and -2.25, Overvalued between 0.75 and 2.25, and Strongly Overvalued above 2.25. The current Forward P/OCF of -3.95 falls within the Strongly Undervalued range.
-3.90
P/FCF
Neuraxis Inc. (NRXS) has a current P/FCF of -3.90. The 5-year average P/FCF is -0.76. The thresholds are as follows: Strongly Undervalued below -3.78, Undervalued between -3.78 and -2.27, Fairly Valued between 0.75 and -2.27, Overvalued between 0.75 and 2.26, and Strongly Overvalued above 2.26. The current Forward P/FCF of -3.90 falls within the Strongly Undervalued range.
Neuraxis Inc (NRXS) has a current Price-to-Book (P/B) ratio of 12.05. Compared to its 3-year average P/B ratio of 2.08 , the current P/B ratio is approximately 479.75% higher. Relative to its 5-year average P/B ratio of 2.08, the current P/B ratio is about 479.75% higher. Neuraxis Inc (NRXS) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -33.20%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -33.20% , the current FCF yield is about -100.00% lower.
11.75
P/B
Median3y
2.08
Median5y
2.08
-21.21
FCF Yield
Median3y
-33.20
Median5y
-33.20
Competitors Valuation Multiple
The average P/S ratio for NRXS's competitors is , providing a benchmark for relative valuation. Neuraxis Inc Corp (NRXS) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 21.72%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of NRXS increased by 15.32% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 666.63K to 811.41K.
The secondary factor is the Margin Expansion, contributed -0.64%to the performance.
Overall, the performance of NRXS in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Neuraxis Inc (NRXS) currently overvalued or undervalued?
What is Neuraxis Inc (NRXS) fair value?
How does NRXS's valuation metrics compare to the industry average?
What is the current P/B ratio for Neuraxis Inc (NRXS) as of Dec 05 2025?
What is the current FCF Yield for Neuraxis Inc (NRXS) as of Dec 05 2025?
What is the current Forward P/E ratio for Neuraxis Inc (NRXS) as of Dec 05 2025?